Fil LTD Sutro Biopharma, Inc. Transaction History

Fil LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$16.88 - $22.38 $11.4 Million - $15.2 Million	-677,416 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$18.03 - $23.82 $1.7 Million - $2.25 Million	-94,374 Reduced 12.23%	677,416 $12.6 Million
Q1 2021 May 14, 2021	BUY	$20.29 - $27.54 $557,690 - $756,964	27,486 Added 3.69%	771,790 $17.6 Million
Q4 2020 Feb 08, 2021	BUY	$10.16 - $23.98 $3.98 Million - $9.39 Million	391,561 Added 111.0%	744,304 $16.2 Million
Q3 2020 Nov 13, 2020	BUY	$7.44 - $13.15 $2.62 Million - $4.64 Million	352,743 New	352,743 $3.55 Million

136

60.9M

77.1K

31.4K

Ticker STRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,161,500
Market Cap $106M
Description
Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...

Get notified when there are updates to the investment portfolio of Fil LTD, based on Form 13F filings with the SEC.

Stay updated on Fil LTD with notifications on news.